Leucine Rich Transmembrane and 0-Methyltransferase Domain Containing (LRTOMT) (Middle Region) antibody (FITC)

Catalog No. ABIN8005606

The FITC-conjugated Rabbit Polyclonal anti-Leucine Rich Transmembrane and 0-Methyltransferase Domain Containing antibody (ABIN8005606) specifically detects Leucine Rich Transmembrane and 0-Methyltransferase Domain Containing in WB and IHC. The antibody is reactive with Human, Mouse and Rat samples.

Quick Overview for Leucine Rich Transmembrane and 0-Methyltransferase Domain Containing (LRTOMT) (Middle Region) antibody (FITC) (ABIN8005606)

Target: Leucine Rich Transmembrane and 0-Methyltransferase Domain Containing (LRTOMT)

Reactivity: Human, Mouse, Rat

Host: Rabbit

Clonality: Polyclonal

Conjugate: FITC

Application: Western Blotting (WB), Immunohistochemistry (IHC)

Product Details

Binding Specificity: Middle Region

Purpose: Anti-LRTOMT Antibody FITC Conjugated

Specificity: No cross reactivity with other proteins.

Cross-Reactivity (Details): No cross-reactivity with other proteins.

Purification: Immunogen affinity purified.

Immunogen: A synthetic peptide corresponding to a sequence in the middle region of human LRTOMT.

Isotype: IgG

Application Details

Application Notes: Western blot, 0.5-1 μg/mL, Human, Mouse, Rat Immunohistochemistry (Paraffin-embedded Section), 1-2 μg/mL, Human, Mouse, Rat

Comment:

Applications are recommended based on the unconjugated antibody.

Restrictions: For Research Use only

Handling

Format: Liquid

Buffer: Each vial contains 50 % glycerol, 0.9 % NaCl, 0.2 % Na2HPO4, 0.02 % Sodium azide.

Preservative: Sodium azide

Precaution of Use: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Storage: -20 °C

Storage Comment: At -20°C for one year from date of receipt. Avoid repeated freezing and thawing. Protect from light.

Expiry Date: 12 months

Target Details

Target: Leucine Rich Transmembrane and 0-Methyltransferase Domain Containing (LRTOMT)

Alternative Name: LRTOMT

Background:

Background: Leucine rich transmembrane and O-methyltransferase domain containing is a protein that in humans is encoded by the LRTOMT gene. It is mapped to 11q13.4. This gene has evolved in primates as a fusion of two ancestral neighboring genes, Lrrc51 and Tomt, which exist as two independent genes in rodents. The fusion gene contains some shared exons, but encodes structurally unrelated proteins, LRTOMT1 and LRTOMT2. Those variants that utilize the more centromere-proximal 3' terminal exon (short transcript form) encode LRTOMT1, while those variants that use a more centromere-distal 3' terminal exon (long transcript form) encode the LRTOMT2 protein. There is a small region within one of the exons of this gene that contains overlapping alternate reading frames for both LRTOMT1 and LRTOMT2. LRTOMT1 shares similarity with the protein encoded by mouse Lrrc51, while LRTOMT2 shares similarity with the protein encoded by mouse Tomt. Alternative splicing results in multiple transcript variants, encoding different isoforms of both LRTOMT1 and LRTOMT2. The LRTOMT1 protein is a leucine-rich repeat-containing protein, while the LRTOMT2 protein is a catechol-O-methyltransferase that catalyzes the transfer of a methyl group from S-adenosyl-L-methionine to a hydroxyl group of catechols and is essential for auditory and vestibular function. Mutations in this gene have been associated with nonsyndromic deafness.

Gene Full Name: leucine rich transmembrane and O-methyltransferase domain containing

Gene ID: 220074

UniProt: Q8WZ04

Pathways: Sensory Perception of Sound